Nick Reed
About
Nick Reed is a scholar working on Epidemiology, Oncology and Obstetrics and Gynecology.
According to data from OpenAlex, Nick Reed has authored 37 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 15 papers in Oncology and 15 papers in Obstetrics and Gynecology. Recurrent topics in Nick Reed's work include Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (14 papers) and Neuroendocrine Tumor Research Advances (10 papers). Nick Reed is often cited by papers focused on Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (14 papers) and Neuroendocrine Tumor Research Advances (10 papers). Nick Reed collaborates with scholars based in United Kingdom, Netherlands and Italy. Nick Reed's co-authors include Bruno Niederle, Ulrich Knigge, Réza Kianmanesh, Christos Toumpanakis, Philippe Morice, Dominik Denschlag, Vesna Kesić, E. P. Krenning, Dermot O’Toole and Ulrich F. Pape and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
In The Last Decade
Nick Reed
33 papers receiving 1.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nick Reed United Kingdom | 17 | 836 | 726 | 540 | 430 | 401 | 37 | 1.6k | ||
| Nicholas Reed United Kingdom | 19 | 426 0.5× | 293 0.4× | 655 1.2× | 839 2.0× | 52 0.1× | 45 | 1.6k | ||
| Deborah Driscoll United States | 23 | 630 0.8× | 252 0.3× | 178 0.3× | 99 0.2× | 85 0.2× | 34 | 1.6k | ||
| J. F. Pringle Canada | 18 | 480 0.6× | 379 0.5× | 355 0.7× | 365 0.8× | 27 0.1× | 22 | 1.3k | ||
| Helen A. Bean Canada | 13 | 258 0.3× | 130 0.2× | 394 0.7× | 343 0.8× | 99 0.2× | 23 | 1.1k | ||
| Sileny Han Belgium | 23 | 1.1k 1.3× | 463 0.6× | 288 0.5× | 279 0.6× | 15 0.0× | 73 | 1.5k | ||
| Vanessa Samouëlian Canada | 17 | 744 0.9× | 389 0.5× | 478 0.9× | 910 2.1× | 17 0.0× | 75 | 1.7k | ||
| George Omura United States | 18 | 619 0.7× | 114 0.2× | 832 1.5× | 533 1.2× | 48 0.1× | 52 | 2.5k | ||
| James J. Burke United States | 17 | 242 0.3× | 321 0.4× | 674 1.2× | 984 2.3× | 16 0.0× | 27 | 1.6k | ||
| Aparna Balachandran United States | 22 | 1.2k 1.4× | 470 0.6× | 102 0.2× | 114 0.3× | 45 0.1× | 42 | 1.6k | ||
| M. Lahousen Austria | 22 | 348 0.4× | 329 0.5× | 1.2k 2.2× | 1.0k 2.4× | 19 0.0× | 82 | 1.9k |
Countries citing papers authored by Nick Reed
Since
Specialization
Citations
This map shows the geographic impact of Nick Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Reed more than expected).
Fields of papers citing papers by Nick Reed
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nick Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Reed. The network helps show where Nick Reed may publish in the future.
Co-authorship network of co-authors of Nick Reed
This figure shows the co-authorship network connecting the top 25 collaborators of Nick Reed. A scholar is included among the top collaborators of Nick Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Reed. Nick Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ramage, John, Krishna Menon, Parthi Srinivasan, et al.. (2024). Current Management of Neuroendocrine Tumour Liver Metastases. Current Oncology Reports. 26(9). 1070–1084.
2.
Graham, Kathryn, et al.. (2022). Overall and cancer specific survival following radical or adjuvant (chemo)radiotherapy in a retrospective cohort of elderly patients with endometrial cancer. European Journal of Gynaecological Oncology.
3.
Morrison, Jo, Peter Baldwin, Lynn Buckley, et al.. (2020). British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 252. 502–525.
4.
Ray‐Coquard, Isabelle, Helen Hatcher, Emmanuelle Bompas, et al.. (2020). A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). International Journal of Gynecological Cancer. 30(10). 1633–1637.
5.
Reed, Nick, Hilary Glen, Gareth Gerrard, et al.. (2019). Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. Clinical Oncology. 32(5). e145–e153.
6.
Knigge, Ulrich, Jaume Capdevila, D.K. Bartsch, et al.. (2017). ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation. Neuroendocrinology. 105(3). 310–319.
7.
Partelli, Stefano, Detlef K. Bartsch, Jaume Capdevila, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours. Neuroendocrinology. 105(3). 255–265.
8.
Sundar, Sudha, Janos Balega, Emma J. Crosbie, et al.. (2017). BGCS uterine cancer guidelines: Recommendations for practice. European Journal of Obstetrics & Gynecology and Reproductive Biology. 213. 71–97.
9.
Qian, W., Juan W. Valle, Denis Talbot, et al.. (2016). Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial. Annals of Oncology. 27. vi146–vi146.
10.
Rodolakis, Alexandros, Ioannis Biliatis, Philippe Morice, et al.. (2015). European Society of Gynecological Oncology Task Force for Fertility Preservation. International Journal of Gynecological Cancer. 25(7). 1258–1265.
11.
Reed, Nick, et al.. (2015). Adequacy of cervical sampling in hysterectomy specimens for endometrial cancer. Annals of Diagnostic Pathology. 19(2). 43–44.
12.
Meyer, Tim, Wendi Qian, Martyn Caplin, et al.. (2014). Capecitabine and streptozocin±cisplatin in advanced gastroenteropancreatic neuroendocrine tumours. European Journal of Cancer. 50(5). 902–911.
13.
Small, William, Andreas du Bois, Saurabha Bhatnagar, et al.. (2009). Practice Patterns of Radiotherapy in Endometrial Cancer Among Member Groups of the Gynecologic Cancer Intergroup. International Journal of Gynecological Cancer. 19(3). 395–399.
14.
Gaffney, David K., Andreas du Bois, Kailash Narayan, et al.. (2009). Patterns of Care for Radiotherapy in Vulvar Cancer: A Gynecologic Cancer Intergroup Study. International Journal of Gynecological Cancer. 19(1). 163–167.
15.
Franchi, Massimo Piergiuseppe, J. Baptist Trimbos, Flavia Zanaboni, et al.. (2007). Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients. European Journal of Cancer. 43(8). 1265–1268.
16.
Gaffney, David K., Andreas du Bois, Kailash Narayan, et al.. (2007). Practice Patterns of Radiotherapy in Cervical Cancer Among Member Groups of the Gynecologic Cancer Intergroup (GCIG). International Journal of Radiation Oncology*Biology*Physics. 68(2). 485–490.
17.
Symonds, Paul, et al.. (2005). Phase one dose finding study of capecitabine (Xeloda®), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer. Gynecologic Oncology. 97(3). 790–795.
18.
Macbeth, Fergus, T. E. Wheldon, D.J. Girling, et al.. (1996). Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. Clinical Oncology. 8(3). 176–181.
19.
Pearce, J. Malcolm, et al.. (1994). A comparative study of the fetal electrocardiogram recorded by the STAN and Nottingham systems. BJOG An International Journal of Obstetrics & Gynaecology. 101(7). 582–586.
20.
McIntosh, J., James Paul, R.P. Symonds, et al.. (1990). Oestrogen and progesterone receptors in carcinoma of the cervix. Clinical Oncology. 2(6). 313–317.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nicholas Reed Breakdown of academic impact, for papers by Deborah Driscoll Breakdown of academic impact, for papers by J. F. Pringle Breakdown of academic impact, for papers by Helen A. Bean Breakdown of academic impact, for papers by Sileny Han Breakdown of academic impact, for papers by Vanessa Samouëlian Breakdown of academic impact, for papers by George Omura Breakdown of academic impact, for papers by James J. Burke Breakdown of academic impact, for papers by Aparna Balachandran Breakdown of academic impact, for papers by M. Lahousen